|
Allowable Use
|
n
|
(% of LHDs)
|
|---|
|
Treatment of ill persons
|
28
|
(90)
|
|
Post-Exposure Prophylaxis (PEP)
|
24
|
(77)
|
|
Pre-Exposure Prophylaxis (PrEP)
|
7
|
(23)
|
|
Allowable use determined by dispensing site
|
8
|
(26)
|
|
Other
|
2
|
(6)
|
- Among the thirty-one local health departments (LHDs) reporting that publicly purchased antivirals were dispensed in their community, Table 2 summarizes the number and proportion of LHDs that allowed publicly purchased antivirals to be used for treatment, post-exposure prophylaxis, and pre-exposure prophylaxis
